Broadfin Healthcare Master Fund Ltd - Net Worth and Insider Trading

Broadfin Healthcare Master Fund Ltd Net Worth

The estimated net worth of Broadfin Healthcare Master Fund Ltd is at least $358 Million dollars as of 2024-11-05. Broadfin Healthcare Master Fund Ltd is the 10% Owner of Mirati Therapeutics Inc and owns about 2,728,601 shares of Mirati Therapeutics Inc (MRTX) stock worth over $160 Million. Broadfin Healthcare Master Fund Ltd is the 10% Owner of Avadel Pharmaceuticals PLC and owns about 4,133,464 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $62 Million. Broadfin Healthcare Master Fund Ltd is also the 10% Owner of Corium International Inc and owns about 3,568,626 shares of Corium International Inc (CORI) stock worth over $45 Million. Besides these, Broadfin Healthcare Master Fund Ltd also holds BioDelivery Sciences International Inc (BDSI) , Progenics Pharmaceuticals Inc (PGNX) , Aratana Therapeutics Inc (PETX) , Aegerion Pharmaceuticals Inc (AEGR) , Societal CDMO Inc (SCTL) , Novelion Therapeutics Inc (NVLNF) , Strata Skin Sciences Inc (SSKN) . Details can be seen in Broadfin Healthcare Master Fund Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Broadfin Healthcare Master Fund Ltd has not made any transactions after 2021-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Broadfin Healthcare Master Fund Ltd

To

Broadfin Healthcare Master Fund Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Broadfin Healthcare Master Fund Ltd owns 12 companies in total, including BioDelivery Sciences International Inc (BDSI) , Novelion Therapeutics Inc (NVLNF) , and Avadel Pharmaceuticals PLC (AVDL) among others .

Click here to see the complete history of Broadfin Healthcare Master Fund Ltd’s form 4 insider trades.

Insider Ownership Summary of Broadfin Healthcare Master Fund Ltd

Ticker Comapny Transaction Date Type of Owner
BDSI BioDelivery Sciences International Inc 2021-11-19 director
NVLNF Novelion Therapeutics Inc 2020-01-09 10 percent owner
AVDL Avadel Pharmaceuticals PLC 2017-06-23 10 percent owner
LIMIT LIMIT 2019-07-18 10 percent owner
LIMIT LIMIT 2018-11-27 10 percent owner
LIMIT LIMIT 2018-05-24 10 percent owner
LIMIT LIMIT 2017-11-16 10 percent owner
LIMIT LIMIT 2017-02-15 10 percent owner
LIMIT LIMIT 2016-11-29 10 percent owner
LIMIT LIMIT 2016-03-11 10 percent owner
LIMIT LIMIT 2015-09-04 10 percent owner & other: See Explanation of Responses
LIMIT LIMIT 2015-01-13 10 percent owner

Broadfin Healthcare Master Fund Ltd Latest Holdings Summary

Broadfin Healthcare Master Fund Ltd currently owns a total of 10 stocks. Among these stocks, Broadfin Healthcare Master Fund Ltd owns 2,728,601 shares of Mirati Therapeutics Inc (MRTX) as of November 16, 2017, with a value of $160 Million and a weighting of 44.73%. Broadfin Healthcare Master Fund Ltd owns 4,133,464 shares of Avadel Pharmaceuticals PLC (AVDL) as of June 23, 2017, with a value of $62 Million and a weighting of 17.33%. Broadfin Healthcare Master Fund Ltd also owns 3,568,626 shares of Corium International Inc (CORI) as of November 17, 2017, with a value of $45 Million and a weighting of 12.64%. The other 7 stocks BioDelivery Sciences International Inc (BDSI) , Progenics Pharmaceuticals Inc (PGNX) , Aratana Therapeutics Inc (PETX) , Aegerion Pharmaceuticals Inc (AEGR) , Societal CDMO Inc (SCTL) , Novelion Therapeutics Inc (NVLNF) , Strata Skin Sciences Inc (SSKN) have a combined weighting of 25.31% among all his current holdings.

Latest Holdings of Broadfin Healthcare Master Fund Ltd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRTX Mirati Therapeutics Inc 2017-11-16 2,728,601 58.70 160,168,879
AVDL Avadel Pharmaceuticals PLC 2017-06-23 4,133,464 15.01 62,043,295
CORI Corium International Inc 2017-11-17 3,568,626 12.68 45,250,178
BDSI BioDelivery Sciences International Inc 2021-11-19 5,158,489 5.59 28,835,954
PGNX Progenics Pharmaceuticals Inc 2017-02-15 6,997,269 4.10 28,688,803
PETX Aratana Therapeutics Inc 2017-12-01 4,294,426 4.92 21,128,576
AEGR Aegerion Pharmaceuticals Inc 2016-09-13 4,361,291 1.97 8,591,743
SCTL Societal CDMO Inc 2018-05-24 2,048,025 1.10 2,252,828
NVLNF Novelion Therapeutics Inc 2018-12-27 1,498,553 0.70 1,051,984
SSKN Strata Skin Sciences Inc 2016-03-11 20,166 3.10 62,515

Holding Weightings of Broadfin Healthcare Master Fund Ltd


Broadfin Healthcare Master Fund Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Broadfin Healthcare Master Fund Ltd has made a total of 0 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years. The most-recent trade in Mirati Therapeutics Inc is the sale of 60,000 shares on November 16, 2017, which brought Broadfin Healthcare Master Fund Ltd around $1 Million.

According to the SEC Form 4 filings, Broadfin Healthcare Master Fund Ltd has made a total of 0 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years. The most-recent trade in Avadel Pharmaceuticals PLC is the sale of 261,000 shares on June 23, 2017, which brought Broadfin Healthcare Master Fund Ltd around $3 Million.

According to the SEC Form 4 filings, Broadfin Healthcare Master Fund Ltd has made a total of 0 transactions in Corium International Inc (CORI) over the past 5 years. The most-recent trade in Corium International Inc is the sale of 500,000 shares on November 17, 2017, which brought Broadfin Healthcare Master Fund Ltd around $5 Million.

More details on Broadfin Healthcare Master Fund Ltd's insider transactions can be found in the Insider Trading History of Broadfin Healthcare Master Fund Ltd table.

Insider Trading History of Broadfin Healthcare Master Fund Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Broadfin Healthcare Master Fund Ltd Trading Performance

GuruFocus tracks the stock performance after each of Broadfin Healthcare Master Fund Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Broadfin Healthcare Master Fund Ltd is 7.07%. GuruFocus also compares Broadfin Healthcare Master Fund Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Broadfin Healthcare Master Fund Ltd within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Broadfin Healthcare Master Fund Ltd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Broadfin Healthcare Master Fund Ltd

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.38 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.41 LIMIT LIMIT LIMIT LIMIT LIMIT

Broadfin Healthcare Master Fund Ltd Ownership Network

Ownership Network List of Broadfin Healthcare Master Fund Ltd

No Data

Ownership Network Relation of Broadfin Healthcare Master Fund Ltd

Insider Network Chart

Broadfin Healthcare Master Fund Ltd Owned Company Details

What does BioDelivery Sciences International Inc do?

Who are the key executives at BioDelivery Sciences International Inc?

Broadfin Healthcare Master Fund Ltd is the director of BioDelivery Sciences International Inc. Other key executives at BioDelivery Sciences International Inc include See Remarks James Vollins , See Remarks Mary Theresa Coelho , and director & Chief Executive Officer Jeffrey Allen Bailey .

BioDelivery Sciences International Inc (BDSI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BioDelivery Sciences International Inc (BDSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioDelivery Sciences International Inc (BDSI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BioDelivery Sciences International Inc (BDSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioDelivery Sciences International Inc Insider Transactions

No Available Data

Broadfin Healthcare Master Fund Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Broadfin Healthcare Master Fund Ltd. You might contact Broadfin Healthcare Master Fund Ltd via mailing address: C/o 20 Genesis Close, Ansbacher House, 2nd Floor, Po Box 1344, Grand Cayman E9 Ky1-1108.